Zi Hui

652 total citations
32 papers, 453 citations indexed

About

Zi Hui is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Zi Hui has authored 32 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Zi Hui's work include Protein Degradation and Inhibitors (10 papers), Histone Deacetylase Inhibitors Research (9 papers) and DNA Repair Mechanisms (5 papers). Zi Hui is often cited by papers focused on Protein Degradation and Inhibitors (10 papers), Histone Deacetylase Inhibitors Research (9 papers) and DNA Repair Mechanisms (5 papers). Zi Hui collaborates with scholars based in China, France and United States. Zi Hui's co-authors include Xiang‐Yang Ye, Tian Xie, Renren Bai, Carmen Garrido, Xingrui He, Yuan Gao, Junlong Zhu, Xiaoying Jiang, Frédéric Lirussi and Liwei Wang and has published in prestigious journals such as ACS Nano, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Zi Hui

29 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zi Hui China 13 262 127 91 27 26 32 453
Petra Grbčić Croatia 13 206 0.8× 239 1.9× 44 0.5× 29 1.1× 25 1.0× 26 496
Elisa Robles‐Escajeda United States 12 210 0.8× 173 1.4× 117 1.3× 30 1.1× 20 0.8× 17 466
Michael Jelínek Czechia 9 198 0.8× 84 0.7× 86 0.9× 41 1.5× 13 0.5× 11 397
Si-Tu Xue China 13 199 0.8× 190 1.5× 78 0.9× 43 1.6× 23 0.9× 30 432
Tengfei Bian United States 11 168 0.6× 69 0.5× 36 0.4× 19 0.7× 14 0.5× 23 363
Shuaishuai Ni China 12 194 0.7× 79 0.6× 49 0.5× 26 1.0× 38 1.5× 22 336
Junjie Lan China 12 175 0.7× 57 0.4× 116 1.3× 48 1.8× 15 0.6× 25 389
Ragu Kanagasabai United States 15 388 1.5× 88 0.7× 120 1.3× 41 1.5× 15 0.6× 22 576
Dinesh Raghu Australia 12 232 0.9× 59 0.5× 132 1.5× 51 1.9× 10 0.4× 20 459
Estela Maria Novak Brazil 11 196 0.7× 98 0.8× 111 1.2× 43 1.6× 26 1.0× 22 503

Countries citing papers authored by Zi Hui

Since Specialization
Citations

This map shows the geographic impact of Zi Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi Hui more than expected).

Fields of papers citing papers by Zi Hui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi Hui. The network helps show where Zi Hui may publish in the future.

Co-authorship network of co-authors of Zi Hui

This figure shows the co-authorship network connecting the top 25 collaborators of Zi Hui. A scholar is included among the top collaborators of Zi Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi Hui. Zi Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chenchen, Miao He, Pengpeng Zhang, et al.. (2025). A novel PARP-ATR dual inhibitor exhibits anti-triple-negative breast cancer activity by inducing excessive DNA damage in the mitotic phase. Biochemical Pharmacology. 241. 117160–117160. 1 indexed citations
2.
Yue, Jing, et al.. (2025). Updated patent review for hematopoietic progenitor kinase (HPK1) inhibitors and degraders (2021-present). Expert Opinion on Therapeutic Patents. 35(4). 387–408.
3.
Wang, Chenchen, et al.. (2025). Design, synthesis, and biological evaluation of aminopyrazine-based ATR/HDACs dual inhibitors. Molecular Diversity. 30(1). 1527–1551.
4.
Hui, Zi, Yueying Xu, Yuan Gao, et al.. (2025). Discovery and optimization of AAK1 inhibitors based on 1H-indazole scaffold for the potential treatment of SARS-CoV-2 infection. Molecular Diversity. 30(1). 463–481. 1 indexed citations
5.
Deng, Yajie, Zi Hui, Lu Liu, et al.. (2025). Modular assembly and evaluation of a TROP2-targeting immunotoxin for cancer therapy. International Journal of Biological Macromolecules. 310(Pt 2). 143311–143311.
6.
Hui, Zi, Carmen Garrido, Frédéric Lirussi, et al.. (2024). Development and therapeutic potential of DNA-dependent protein kinase inhibitors. Bioorganic Chemistry. 150. 107608–107608. 2 indexed citations
7.
Xu, Yueying, Xia Yao, Zi Hui, et al.. (2024). Design, synthesis, and biological evaluation of novel AAK1/HDACs dual inhibitors against SARS-CoV-2 entry. Bioorganic Chemistry. 153. 107973–107973. 2 indexed citations
8.
Xu, Yueying, Xia Yao, Chenchen Wang, et al.. (2024). Design, synthesis and biological evaluation of novel 1,2,4a,5-tetrahydro-4H-benzo[b][1,4]oxazino[4,3-d][1,4]oxazine-based AAK1 inhibitors with anti-viral property against SARS-CoV-2. European Journal of Medicinal Chemistry. 268. 116232–116232. 2 indexed citations
9.
Qi, Xiang, Yuan Gao, Bing Xu, et al.. (2023). Design, synthesis and anti-tumor efficacy evaluation of novel 1,3-diaryl propane-based polyphenols obtained from Claisen rearrangement reaction. Bioorganic Chemistry. 140. 106753–106753. 2 indexed citations
10.
Hui, Zi, Hao Wen, Junlong Zhu, et al.. (2023). Discovery of plant-derived anti-tumor natural products: Potential leads for anti-tumor drug discovery. Bioorganic Chemistry. 142. 106957–106957. 46 indexed citations
11.
Itoh, Yukihiro, Peng Zhan, T Tojo, et al.. (2023). Discovery of Selective Histone Deacetylase 1 and 2 Inhibitors: Screening of a Focused Library Constructed by Click Chemistry, Kinetic Binding Analysis, and Biological Evaluation. Journal of Medicinal Chemistry. 66(22). 15171–15188. 12 indexed citations
12.
Hui, Zi, Jianhua Zhong, Jiabao Guan, et al.. (2023). Design of S-band photoinjector with high bunch charge and low emittance based on multi-objective genetic algorithm. Nuclear Science and Techniques. 34(3). 5 indexed citations
13.
Li, Junjie, Rui Zhao, Fengfeng Xu, et al.. (2023). Discovery of anti-inflammatory natural flavonoids: Diverse scaffolds and promising leads for drug discovery. European Journal of Medicinal Chemistry. 260. 115791–115791. 28 indexed citations
14.
Dong, Jinyun, Zi Hui, Carmen Garrido, et al.. (2022). An updated patent review of protein arginine N-methyltransferase inhibitors (2019–2022). Expert Opinion on Therapeutic Patents. 32(12). 1185–1205. 16 indexed citations
15.
Hui, Zi, et al.. (2022). Discovery of small-molecule ATR inhibitors for potential cancer treatment: a patent review from 2014 to present. Expert Opinion on Therapeutic Patents. 32(4). 401–421. 9 indexed citations
16.
Bai, Renren, Junlong Zhu, Qing Mao, et al.. (2022). Second generation β-elemene nitric oxide derivatives with reasonable linkers: potential hybrids against malignant brain glioma. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 379–385. 52 indexed citations
17.
Hui, Zi, Yuan Gao, Yang Ye, et al.. (2022). Design, synthesis and antitumor efficacy evaluation of a series of novel β-elemene-based macrocycles. Bioorganic & Medicinal Chemistry. 74. 117049–117049. 11 indexed citations
18.
He, Xingrui, Zi Hui, Li Xu, et al.. (2021). Medicinal chemistry updates of novel HDACs inhibitors (2020 to present). European Journal of Medicinal Chemistry. 227. 113946–113946. 51 indexed citations
19.
Hui, Zi, et al.. (2020). Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010–present). Expert Opinion on Therapeutic Patents. 31(5). 435–452. 44 indexed citations
20.
He, Xingrui, Yuan Gao, Zi Hui, et al.. (2020). 4-Hydroxy-3-methylbenzofuran-2-carbohydrazones as novel LSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(10). 127109–127109. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petra Grbčić Breakdown of academic impact, for papers by Elisa Robles‐Escajeda Breakdown of academic impact, for papers by Michael Jelínek Breakdown of academic impact, for papers by Si-Tu Xue Breakdown of academic impact, for papers by Tengfei Bian Breakdown of academic impact, for papers by Shuaishuai Ni Breakdown of academic impact, for papers by Junjie Lan Breakdown of academic impact, for papers by Ragu Kanagasabai Breakdown of academic impact, for papers by Dinesh Raghu Breakdown of academic impact, for papers by Estela Maria Novak
Rankless by CCL
2026